陳建成 陳栩俊 梁忠誠
【摘要】 目的 分析ⅢA期非小細胞肺癌治療中肺癌根治術淋巴結清掃的應用價值。方法 120例
ⅢA期非小細胞肺癌患者, 按隨機性原則將其分為對照組與觀察組, 每組60例。對照組接受傳統肺癌根治術治療, 觀察組接受肺癌根治術淋巴結清掃治療。對比兩組的臨床療效。結果 觀察組的淋巴結清除數(29.8±4.6)粒多于對照組的(23.6±8.2)粒, 差異具有統計學意義(P<0.01)。觀察組縱隔轉移率10.00%、復發率38.33%均低于對照組的26.67%、56.67%, 差異均具有統計學意義(P<0.05)。經隨訪可知, 兩組存活1年比例比較差異無統計學意義(P>0.05);觀察組存活3、5年率61.67%、48.33%均高于對照組的43.33%、30.00%, 差異均具有統計學意義(P<0.05)。結論 ⅢA期非小細胞肺癌治療中肺癌根治術淋巴結清掃可有效控制縱隔轉移和復發, 提升生存質量, 值得推廣。
【關鍵詞】 非小細胞肺癌;肺癌根治術;淋巴結清掃
DOI:10.14163/j.cnki.11-5547/r.2017.25.001
【Abstract】 Objective To analyze the application value of lymph node dissection for stage ⅢA non-small cell lung cancer after radical resection of lung cancer. Methods A total of 120 stage ⅢA non-small cell lung cancer patients were randomly divided into control group and observation group, with 60 cases in each group. The control group was treated with traditional radical resection of lung cancer, and the observation group was treated with lymph node dissection after radical resection of lung cancer. Clinical efficacy in two groups was compared. Results The observation group had more lymph node dissection number as (29.8±4.6) pieces than (23.6±8.2) pieces in the control group, and the difference had statistical significance (P<0.01). The observation group had lower mediastinal transfer rate as 10.00% and recurrence rate as 38.33% than 26.67% and 56.67% in the control group, and their difference had statistical significance (P<0.05). The follow-up showed that there was no statistically significant difference in survival rate in 1 year in two groups (P>0.05). The observation group had all higher survival rate in 3 and 5 years as 61.67% and 48.33% than 43.33% and 30.00% in the control group, and their difference had statistical significance (P<0.05). Conclusion Lymph node dissection for stage ⅢA non-small cell lung cancer after radical resection of lung cancer can effectively control mediastinal metastasis and recurrence, improve the quality of life. So it is worth promoting.
【Key words】 Non-small cell lung cancer; Radical resection of lung cancer; Lymph node dissection
非小細胞肺癌(non-small cell lung cancer)是腺癌、鱗狀細胞癌的統稱, 生長分裂緩慢, 不易擴散, 但近年來病死率呈上升趨勢[1]。傳統肺癌根治術療效不佳, 缺乏遠期期望。為此, 本文特提出肺癌根治術淋巴結清掃, 為ⅢA期非小細胞肺癌的臨床治療提供參考。
1 資料與方法
1. 1 一般資料 選取2010年1月~2011年12月收治的120例ⅢA期非小細胞肺癌患者為研究對象, 按隨機性原則將其分為對照組和觀察組, 每組60例。對照組中男48例, 女12例;年齡38~65歲, 平均年齡(52.8±12.3)歲;疾病類型:腺癌35例, 鱗狀細胞癌25例;TNM分期:T1N2M0 16例、
T2N2M0 18例、T3N2M0 12例、T3N1M0 14例。觀察組中男48例, 女12例;年齡38~65歲, 平均年齡(52.8±12.3)歲;疾病類型:腺癌36例, 鱗狀細胞癌24例;TNM分期:T1N2M0 15例、T2N2M0 17例、T3N2M0 14例、T3N1M0 14例。兩組一般資料比較差異無統計學意義(P>0.05), 具有可比性。endprint
1. 2 方法 對照組接受傳統肺癌根治術, 觀察組接受肺癌根治術淋巴結清掃:清掃9、10、11、12區淋巴結, 行病灶切除后剪開縱隔胸膜行縱隔淋巴結清掃, 依次清掃左側4~9區,
右側2~4區及7~9區[2]。
1. 3 觀察指標 對比兩組的淋巴結清除數, 縱隔轉移、復發情況及生存質量。……p>